CS236782B2 - Processing of 5 s-(2r-butyl)peptidergotalkaloid - Google Patents

Processing of 5 s-(2r-butyl)peptidergotalkaloid Download PDF

Info

Publication number
CS236782B2
CS236782B2 CS83925A CS92583A CS236782B2 CS 236782 B2 CS236782 B2 CS 236782B2 CS 83925 A CS83925 A CS 83925A CS 92583 A CS92583 A CS 92583A CS 236782 B2 CS236782 B2 CS 236782B2
Authority
CS
Czechoslovakia
Prior art keywords
compound
acid
formula
butyl
ether
Prior art date
Application number
CS83925A
Other languages
Czech (cs)
English (en)
Inventor
Rudolf K A Giger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CS236782B2 publication Critical patent/CS236782B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS83925A 1982-02-12 1983-02-10 Processing of 5 s-(2r-butyl)peptidergotalkaloid CS236782B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH89382 1982-02-12
CH692482 1982-11-29

Publications (1)

Publication Number Publication Date
CS236782B2 true CS236782B2 (en) 1985-05-15

Family

ID=25686031

Family Applications (1)

Application Number Title Priority Date Filing Date
CS83925A CS236782B2 (en) 1982-02-12 1983-02-10 Processing of 5 s-(2r-butyl)peptidergotalkaloid

Country Status (31)

Country Link
US (1) US4737499A (fr)
KR (1) KR890000813B1 (fr)
AT (1) AT382874B (fr)
AU (1) AU564596B2 (fr)
CA (1) CA1245641A (fr)
CH (1) CH658249A5 (fr)
CS (1) CS236782B2 (fr)
CY (1) CY1432A (fr)
DD (1) DD208356A5 (fr)
DE (1) DE3303616A1 (fr)
DK (1) DK62283A (fr)
ES (1) ES8500280A1 (fr)
FI (1) FI71941C (fr)
FR (1) FR2522663B1 (fr)
GB (1) GB2114980B (fr)
GR (1) GR77417B (fr)
HK (1) HK53088A (fr)
IE (1) IE54501B1 (fr)
IL (1) IL67883A (fr)
IT (1) IT1197571B (fr)
KE (1) KE3811A (fr)
MY (1) MY8600569A (fr)
NL (1) NL8300484A (fr)
NO (1) NO164773C (fr)
NZ (1) NZ203252A (fr)
PH (1) PH21234A (fr)
PL (1) PL140363B1 (fr)
PT (1) PT76222B (fr)
SE (1) SE455097B (fr)
SG (1) SG22588G (fr)
WO (1) WO1983002775A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571927B2 (en) * 1979-06-12 1988-04-28 Sandoz Ltd. A 2-methyl ergot peptide alkaloid
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US6831216B2 (en) * 2002-05-21 2004-12-14 Holden's Foundation Seeds Llc Inbred corn line LH247

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH503031A (de) * 1967-04-12 1971-02-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
CH520679A (de) * 1967-08-02 1972-03-31 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
CH505102A (de) * 1967-11-01 1971-03-31 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
SE397093B (sv) * 1973-07-09 1977-10-17 Sandoz Ag Forfarande for framstellning av oktahydro-oxazolo(3,2-a)pyrrolo(2,1-c)pyrazinderivat
CH602765A5 (fr) * 1974-09-27 1978-07-31 Sandoz Ag
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen

Also Published As

Publication number Publication date
MY8600569A (en) 1986-12-31
FR2522663B1 (fr) 1985-06-14
IE54501B1 (en) 1989-10-25
WO1983002775A1 (fr) 1983-08-18
AU564596B2 (en) 1987-08-20
KR890000813B1 (ko) 1989-04-08
AU1129283A (en) 1983-08-18
PH21234A (en) 1987-08-21
IE830282L (en) 1983-08-12
US4737499A (en) 1988-04-12
DK62283A (da) 1983-08-13
HK53088A (en) 1988-07-22
PT76222B (en) 1986-01-15
FI830399A0 (fi) 1983-02-04
ATA47583A (de) 1986-09-15
CA1245641A (fr) 1988-11-29
GR77417B (fr) 1984-09-13
CY1432A (en) 1988-09-02
NO164773C (no) 1990-11-14
DE3303616A1 (de) 1983-08-25
FI830399L (fi) 1983-08-13
AT382874B (de) 1987-04-27
ES519687A0 (es) 1984-10-01
PT76222A (en) 1983-03-01
SE8300711D0 (sv) 1983-02-10
NZ203252A (en) 1986-08-08
NL8300484A (nl) 1983-09-01
DK62283D0 (da) 1983-02-11
NO164773B (no) 1990-08-06
IL67883A0 (en) 1983-06-15
FR2522663A1 (fr) 1983-09-09
FI71941C (fi) 1987-03-09
IL67883A (en) 1986-03-31
PL140363B1 (en) 1987-04-30
CH658249A5 (de) 1986-10-31
IT1197571B (it) 1988-12-06
PL240540A1 (en) 1984-06-18
SE8300711L (sv) 1983-08-13
GB8303475D0 (en) 1983-03-16
GB2114980A (en) 1983-09-01
KE3811A (en) 1988-08-05
SG22588G (en) 1988-07-15
FI71941B (fi) 1986-11-28
SE455097B (sv) 1988-06-20
IT8347702A0 (it) 1983-02-11
ES8500280A1 (es) 1984-10-01
GB2114980B (en) 1985-10-30
NO830416L (no) 1983-08-15
DD208356A5 (de) 1984-05-02
KR840003642A (ko) 1984-09-15

Similar Documents

Publication Publication Date Title
RU2136682C1 (ru) Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
JP2005325138A (ja) 多環式グアニンホスホジエステラーゼｖ阻害剤
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
WO2007129111A1 (fr) Dérivés de diazépine en tant qu'antagonistes de 5-ht2a
KR100717489B1 (ko) 피리도피리미디논 화합물, 이의 제조 방법 및 이를함유하는 약제 조성물
CZ290325B6 (cs) Alkoxyalkylkarbamáty imidazo [1,2-a] pyridinů a farmaceutický prostředek je obsahující
US4432990A (en) 5-Aminoimidazoles as immunoregulants
CS236782B2 (en) Processing of 5 s-(2r-butyl)peptidergotalkaloid
EP0520435A2 (fr) Dérivés du composé DC 89
EP0495889A1 (fr) DERIVES D'IMINOMETHANODIBENZO(a,d)CYCLOHEPTENE EN TANT QU'AGENTS NEUROPROTECTEURS
SK197A3 (en) Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
US4609657A (en) Ergot peptide alkaloid derivatives, processes for their preparation and pharmaceutical compositions containing them
US4861793A (en) D-nor-7-ergoline derivatives having anti-Parkinson and antipsychosis activity and pharmaceutical compositions containing them
EP0847400B1 (fr) Polymorphes du promedicament 6-n-(l-ala-l-ala)-trovafloxacine
US20040038966A1 (en) Cyclic amine derivatives and use thereof
CZ280931B6 (cs) Opticky aktivní karboxamidové deriváty, farmaceutický prostředek s analgetickým účinkem a prostředek s agonistickým účinkem vzhledem ke k-receptorům
US4871765A (en) Amine derivative and its salt and anti-ulcer agent containing the same
FI83869B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat.
FI88039B (fi) Foerfarande foer framstaellning av 2,3-dihydro-1-(8-metyl-1,2,4-triatsolo/4,3-b/pyridazin-6-yl)-4(1h)-pyridinon
HU187003B (en) Process for producing ergot-alkaloides
CS226200B2 (cs) Způsob výroby derivátů 4-amino-5-alkylsulfonylorthoanisamidů
CS245799B2 (cs) Způsob výroby derivátů ergolinu